UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review

Frontiers in immunology, 2020-07, Vol.11, p.1477-1477

2020

Volltextzugriff (PDF)

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

International journal of molecular sciences, 2021-02, Vol.22 (5), p.2449

2021

Volltextzugriff (PDF)

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)

International journal of molecular sciences, 2020-03, Vol.21 (6), p.2076

2020

Volltextzugriff (PDF)

Differential Impact of Biologic Therapy on Heart Function Biomarkers in Rheumatoid Arthritis Patients: Observational Study on Etanercept, Adalimumab, and Tocilizumab

Current pharmaceutical design, 2022-01, Vol.28 (24), p.2029-2037

2022

Volltextzugriff (PDF)

Hyperferritinaemia: An Iron Sword of Autoimmunity

Current pharmaceutical design, 2019-01, Vol.25 (27), p.2909-2918

2019

Volltextzugriff (PDF)

Editorial: Autoimmunity and cardiovascular diseases

Frontiers in cardiovascular medicine, 2023-07, Vol.10, p.1249525-1249525

2023

Volltextzugriff (PDF)

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis

International journal of molecular sciences, 2020-10, Vol.21 (19), p.7390

2020

Volltextzugriff (PDF)

Vitamin D Status in Patients with Primary Antiphospholipid Syndrome (PAPS): A Systematic Review and Meta-Analysis

Antibodies (Basel), 2024-03, Vol.13 (1), p.22

2024

Volltextzugriff (PDF)

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment

Journal of clinical medicine, 2019-05, Vol.8 (5), p.625

2019

Volltextzugriff (PDF)

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

International journal of molecular sciences, 2018-06, Vol.19 (6), p.1739

Kotyla, Przemyslaw J

2018

Volltextzugriff (PDF)

Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus

International journal of molecular sciences, 2023-05, Vol.24 (11), p.9470

2023

Volltextzugriff (PDF)

Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis

PloS one, 2020-01, Vol.15 (1), p.e0227836-e0227836

2020

Volltextzugriff (PDF)

Immunogenetics of Systemic Sclerosis

Genes, 2024-05, Vol.15 (5), p.586

2024

Volltextzugriff (PDF)

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus

Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (8), p.936

2022

Volltextzugriff (PDF)

Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis

Autoimmunity reviews, 2019-11, Vol.18 (11), p.102392, Article 102392

2019

Volltextzugriff (PDF)

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?

BioMed research international, 2018-01, Vol.2018, p.7492904-9

2018

Volltextzugriff (PDF)

Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12264

2022

Volltextzugriff (PDF)

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis

Pharmaceuticals (Basel, Switzerland), 2023-07, Vol.16 (8), p.1066

2023

Volltextzugriff (PDF)

Dercum's disease (adiposis dolorosa): a review of clinical presentation and management

Reumatologia, 2019, Vol.57 (5), p.281-287

2019

Volltextzugriff (PDF)

CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis

Scientific reports, 2021-10, Vol.11 (1), p.19598-7, Article 19598

2021

Volltextzugriff (PDF)

The prevalence and role of functional autoantibodies to angiotensin-converting-enzyme-2 in patients with systemic sclerosis

Autoimmunity (Chur, Switzerland), 2021-06, Vol.54 (4), p.181-186

2021

Volltextzugriff (PDF)

Insulin resistance varies across connective tissue diseases patients: comparison between rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis

Clinical and experimental rheumatology, 2019-11, Vol.37 Suppl 122 (6), p.14

Kotyla, Przemyslaw J

2019

Volltextzugriff (PDF)

A horse, a horse, my kingdom for a horse! Why do we still not know everything about systemic sclerosis?

Rheumatology Forum, 2023-09, Vol.9 (3), p.93-95

2023

Volltextzugriff (PDF)

Adhesion molecules: a way to understand lupus

Reumatologia, 2022-01, Vol.60 (2), p.133-141

2022

Volltextzugriff (PDF)

Low dose of simvastatin reduces disease activity and improves endothelial function in patients with systemic lupus erythematosus

Clinical and experimental rheumatology, 2019-11, Vol.37 Suppl 122 (6), p.6

Kotyla, Przemyslaw J

2019

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(44)
Humans
(39)
Rheumatology
(19)
Female
(15)
Middle Aged
(11)
Systemic Sclerosis
(11)
Disease
(10)
Review
(10)
Arthritis, Rheumatoid - Drug Therapy
(9)
Autoimmune Diseases
(9)
Cytokines
(9)
Adult
(8)
Immunology
(8)
Male
(8)
Rheumatoid Arthritis
(8)
Scleroderma
(8)
Physical Sciences
(7)
Systemic Lupus Erythematosus
(7)
Animals
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)

Differential Impact of Biologic Therapy on Heart Function Biomarkers in Rheumatoid Arthritis Patients: Observational Study on Etanercept, Adalimumab, and Tocilizumab

Hyperferritinaemia: An Iron Sword of Autoimmunity

Editorial: Autoimmunity and cardiovascular diseases

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis

Vitamin D Status in Patients with Primary Antiphospholipid Syndrome (PAPS): A Systematic Review and Meta-Analysis

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus

Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis

Immunogenetics of Systemic Sclerosis

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus

Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?

Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis

Dercum's disease (adiposis dolorosa): a review of clinical presentation and management

CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis

The prevalence and role of functional autoantibodies to angiotensin-converting-enzyme-2 in patients with systemic sclerosis

Insulin resistance varies across connective tissue diseases patients: comparison between rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis

A horse, a horse, my kingdom for a horse! Why do we still not know everything about systemic sclerosis?

Adhesion molecules: a way to understand lupus

Low dose of simvastatin reduces disease activity and improves endothelial function in patients with systemic lupus erythematosus

Suchergebnisse filtern